Serum organochlorines and breast cancer: a case-control study among African-American women.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 1839921)

Published in Cancer Causes Control on February 01, 2007

Authors

Nicole M Gatto1, Matthew P Longnecker, Michael F Press, Jane Sullivan-Halley, Roberta McKean-Cowdin, Leslie Bernstein

Author Affiliations

1: Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, USC/Norris Comprehensive Center, 1441 Eastlake Avenue, Room 4449, Los Angeles, CA 90033, USA.

Articles cited by this

Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst (1993) 8.11

Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol (1989) 6.02

Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst (1994) 5.92

A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem (1983) 4.39

Hormonal carcinogenesis. Carcinogenesis (2000) 3.86

Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem (1973) 3.69

A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta (1977) 3.44

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res (2005) 2.85

Quantitative PCB standards for electron capture gas chromatography. J Chromatogr Sci (1973) 2.68

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol (2002) 2.67

The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health (1997) 2.44

Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health (1986) 2.36

The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21

Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health (1992) 2.10

The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res (2002) 2.07

1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst (2001) 2.05

Pesticides and cancer. Cancer Causes Control (1997) 2.00

High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst (1994) 1.81

Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev (1999) 1.74

Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev (2000) 1.70

Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr (2000) 1.50

Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev (2002) 1.50

p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol (1999) 1.45

Ethnicity-related variation in breast cancer risk factors. Cancer (2003) 1.39

Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35

Demographic and seasonal influences on human serum pesticide residue levels. J Toxicol Environ Health (1989) 1.30

Pesticide use and breast cancer risk among farmers' wives in the agricultural health study. Am J Epidemiol (2005) 1.30

Control recruitment in population-based case-control studies. Epidemiology (2006) 1.30

Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control (1995) 1.27

Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev (2000) 1.24

Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med (1997) 1.22

Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med (1977) 1.21

Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res (1984) 1.17

Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2000) 1.16

Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids (2002) 1.15

DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ (1997) 1.13

Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer (1990) 1.12

Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol (1976) 1.11

A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev (2005) 1.07

Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev (2000) 1.07

Pollutants in breast milk. Arch Pediatr Adolesc Med (1996) 1.05

The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys (2004) 1.04

p53 mutations and expression in breast carcinoma in situ. Am J Pathol (2000) 0.99

Menstrual risk factors and early-onset breast cancer. Cancer Causes Control (2000) 0.99

DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol (1999) 0.96

Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev (2003) 0.96

Gas chromatographic determination of polychlorinated biphenyls (as Aroclor 1254) in serum: collaborative study. J Assoc Off Anal Chem (1989) 0.96

Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control (2001) 0.94

Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol (2004) 0.91

Measurement of organochlorine levels in postprandial serum or in blood collected in serum separator tubes. Cancer Epidemiol Biomarkers Prev (1996) 0.89

Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Breast Cancer Res Treat (2002) 0.88

A survey of measured levels and dietary sources of selected organochlorine pesticide residues and metabolites in human sera from a rural population. Am J Public Health (1988) 0.88

Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol Biomarkers Prev (2005) 0.88

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer (2005) 0.88

Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Cancer Causes Control (2003) 0.86

Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapies. Hybridoma (1999) 0.85

Lactation and breast cancer risk. J Mammary Gland Biol Neoplasia (1997) 0.84

Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomarkers Prev (1996) 0.84

Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol Rev (2003) 0.83

Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause (1998) 0.82

HERe-2 stay: the continuing importance of translational research in breast cancer. J Natl Cancer Inst (2004) 0.81

Articles by these authors

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol (2006) 25.12

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol (2013) 12.57

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med (2007) 8.02

Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol (2009) 5.66

Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer. J Clin Oncol (2009) 4.69

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56

Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93

Fish intake during pregnancy and early cognitive development of offspring. Epidemiology (2004) 3.83

High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control (2002) 3.81

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. J Clin Oncol (2008) 3.35

Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30

Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev (2003) 3.11

The landscape of recombination in African Americans. Nature (2011) 3.06

Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06

Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88

Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res (2005) 2.85

Long-term exposure to constituents of fine particulate air pollution and mortality: results from the California Teachers Study. Environ Health Perspect (2009) 2.72

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol (2002) 2.67

Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65

Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst (2004) 2.62

FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet (2009) 2.62

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med (2013) 2.54

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol (2010) 2.48

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36

Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer (2012) 2.33

Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27

Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology (2007) 2.22

Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med (2011) 2.21

The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21

Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health (2004) 2.17

Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16

HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw (2006) 2.15

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood (2006) 2.15

Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast Cancer (2005) 2.12

Light at night and breast cancer risk among California teachers. Epidemiology (2014) 2.06

Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer. J Natl Cancer Inst (2004) 2.06

Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (2012) 2.05

Regional variations in breast cancer among california teachers. Epidemiology (2004) 2.04

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer (2003) 2.03

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03

Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01

Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01

Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01

Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol (2008) 2.01

Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ Res (2008) 2.01

Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. J Clin Oncol (2005) 1.99

Perfluorinated compounds and subfecundity in pregnant women. Epidemiology (2012) 1.98

Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol (2011) 1.97

Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96

Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer (2002) 1.95

Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet (2011) 1.94

Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis (2007) 1.94

Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst (2004) 1.93

Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology (2007) 1.92

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91

Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85

Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol (2006) 1.83

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst (2008) 1.81

19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81

Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet (2009) 1.81

Association of tamoxifen and uterine sarcoma. J Clin Oncol (2002) 1.80

Prevalence of myopia, hyperopia, and astigmatism in non-Hispanic white and Asian children: multi-ethnic pediatric eye disease study. Ophthalmology (2013) 1.78

Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study. Blood (2011) 1.76

In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am J Epidemiol (2005) 1.75

Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75

Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril (2011) 1.74

Risk factors associated with childhood strabismus: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies. Ophthalmology (2011) 1.70

Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat (2008) 1.69